Edits to 'https://fairsharing.org/FAIRsharing.3f9n4y' by 'The FAIRsharing Team' at 16:35, 05 Oct 2020 (not approved):
'user_defined_tags' has been modified:
Before:
Approved drug
After:
Added:
Removed:
Approved drug
'miriam_id' has been modified:
Before:
After: None
'onto_domains' has been modified:
Before:
Abstract
Gene report
Rare Disorder
Text mining
disease
disease phenotype
disease process modeling objective
gene-disease association
phenotype
target
After:
Abstract
Approved drug
Gene report
Rare Disorder
Text mining
disease
disease phenotype
disease process modeling objective
gene-disease association
phenotype
target
Added:
Approved drug
Removed:
Edits to 'https://fairsharing.org/FAIRsharing.3f9n4y' by 'The FAIRsharing Team' at 14:18, 30 Sep 2019 (approved):
'organizations' has been modified:
Before:
European Commission under FP7 Grant Agreement|http://ec.europa.eu/research/fp7/index_en.cfm?pg=documents|Undefined
BioGen|https://www.biogen.com/|Maintains
GlaxoSmithKline|http://www.gsk.com|Funds
The Wellcome Trust Sanger Institute, The Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK|http://www.sanger.ac.uk|Maintains
After:
GlaxoSmithKline|http://www.gsk.com|Funds
BioGen|https://www.biogen.com/|Maintains
The Wellcome Trust Sanger Institute, The Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK|http://www.sanger.ac.uk|Maintains
European Commission under FP7 Grant Agreement|http://ec.europa.eu/research/fp7/index_en.cfm?pg=documents|Funds
Added:
European Commission under FP7 Grant Agreement|http://ec.europa.eu/research/fp7/index_en.cfm?pg=documents|Funds
Removed:
European Commission under FP7 Grant Agreement|http://ec.europa.eu/research/fp7/index_en.cfm?pg=documents|Undefined
'related_databases' has been modified:
Before:
ChEMBL
Expression Atlas
Reactome - a curated knowledgebase of biological pathways
UniProt Knowledgebase
After:
ChEMBL
Expression Atlas
Europe PubMed Central
Reactome - a curated knowledgebase of biological pathways
UniProt Knowledgebase
European Variation Archive
Genome-Wide Association Studies Catalog
Added:
Europe PubMed Central
European Variation Archive
Genome-Wide Association Studies Catalog
Removed:
'supportLinks' has been modified:
Before:
FAQ|https://www.targetvalidation.org/faq
email|support@targetvalidation.org
online documentation|https://www.targetvalidation.org/about
online documentation|https://www.targetvalidation.org/documentation/api
training|https://www.targetvalidation.org/outreach
twitter|@targetvalidate
After:
FAQ|https://docs.targetvalidation.org/faq/frequently-asked-questions
blog|http://blog.opentargets.org/
help|https://docs.targetvalidation.org/
online documentation|https://www.targetvalidation.org/about
tess training|https://tess.elixir-europe.org/materials/text-mining-key-concepts-and-applications
tess training|https://tess.elixir-europe.org/materials/open-targets-using-genetics-and-functional-genomics-to-identify-and-prioritise-targets-for-new-medicines
training|https://www.targetvalidation.org/outreach
twitter|@targetvalidate
Added:
FAQ|https://docs.targetvalidation.org/faq/frequently-asked-questions
blog|http://blog.opentargets.org/
help|https://docs.targetvalidation.org/
tess training|https://tess.elixir-europe.org/materials/text-mining-key-concepts-and-applications
tess training|https://tess.elixir-europe.org/materials/open-targets-using-genetics-and-functional-genomics-to-identify-and-prioritise-targets-for-new-medicines
Removed:
FAQ|https://www.targetvalidation.org/faq
email|support@targetvalidation.org
online documentation|https://www.targetvalidation.org/documentation/api
'description' has been modified:
Before: Open Targets designed and developed an integration and visualization platform that provides evidence about the association of known and potential drug targets with diseases. The platform is designed to support identification and prioritization of biological targets for follow-up. Each drug target is linked to a disease using integrated genome-wide data from a broad range of data sources. The platform provides either a target-centric workflow to identify diseases that may be associated with a specific target, or a disease-centric workflow to identify targets that may be associated with a specific disease. Users can easily transition between these target- and disease-centric workflows.
After: Open Targets is a data integration platform for access to and visualisation of potential drug targets associated with disease. Each drug target is linked to a disease using integrated genome-wide data from a broad range of data sources.
'countries' has been modified:
Before:
United Kingdom
United States
After:
China
United Kingdom
United States
Added:
China
Removed:
'licences' has been modified:
Before:
After:
Open Target Terms of Use|https://www.targetvalidation.org/terms-of-use|Data
Added:
Open Target Terms of Use|https://www.targetvalidation.org/terms-of-use|Data
Removed:
'dataProcesses' has been modified:
Before:
After:
Download
Added:
Download
Removed:
'contactEmail' has been modified:
Before: contact@opentargets.org
After: support@targetvalidation.org
'user_defined_tags' has been modified:
Before:
Approved drug
Drug Target
Mode of action
Validation
After:
Approved drug
Added:
Removed:
Drug Target
Mode of action
Validation
'contact' has been modified:
Before: Open Targets core team
After: Open Targets Team
'miriam_id' has been modified:
Before: None
After:
'publications' has been modified:
Before:
Open Targets: a platform for therapeutic target identification and validation.|Koscielny G,An P,Carvalho-Silva D,Cham JA,Fumis L,Gasparyan R,Hasan S,Karamanis N,Maguire M,Papa E,Pierleoni A,Pignatelli M,Platt T,Rowland F,Wankar P,Bento AP,Burdett T,Fabregat A,Forbes S,Gaulton A,Gonzalez CY,Hermjakob H,Hersey A,Jupe S,Kafkas S,Keays M,Leroy C,Lopez FJ,Magarinos MP,Malone J,McEntyre J,Munoz-Pomer Fuentes A,O'Donovan C,Papatheodorou I,Parkinson H,Palka B,Paschall J,Petryszak R,Pratanwanich N,Sarntivijal S,Saunders G,Sidiropoulos K,Smith T,Sondka Z,Stegle O,Tang YA,Turner E,Vaughan B,Vrousgou O,Watkins X,Martin MJ,Sanseau P,Vamathevan J,Birney E,Barrett J,Dunham I|Nucleic Acids Res|2016
After:
Open Targets: a platform for therapeutic target identification and validation.|Koscielny G,An P,Carvalho-Silva D,Cham JA,Fumis L,Gasparyan R,Hasan S,Karamanis N,Maguire M,Papa E,Pierleoni A,Pignatelli M,Platt T,Rowland F,Wankar P,Bento AP,Burdett T,Fabregat A,Forbes S,Gaulton A,Gonzalez CY,Hermjakob H,Hersey A,Jupe S,Kafkas S,Keays M,Leroy C,Lopez FJ,Magarinos MP,Malone J,McEntyre J,Munoz-Pomer Fuentes A,O'Donovan C,Papatheodorou I,Parkinson H,Palka B,Paschall J,Petryszak R,Pratanwanich N,Sarntivijal S,Saunders G,Sidiropoulos K,Smith T,Sondka Z,Stegle O,Tang YA,Turner E,Vaughan B,Vrousgou O,Watkins X,Martin MJ,Sanseau P,Vamathevan J,Birney E,Barrett J,Dunham I|Nucleic Acids Res|2016
Open Targets Platform: new developments and updates two years on.|Carvalho-Silva D,Pierleoni A,Pignatelli M,Ong C,Fumis L,Karamanis N,Carmona M,Faulconbridge A,Hercules A,McAuley E,Miranda A,Peat G,Spitzer M,Barrett J,Hulcoop DG,Papa E,Koscielny G,Dunham I|Nucleic Acids Res|2018
Added:
Open Targets Platform: new developments and updates two years on.|Carvalho-Silva D,Pierleoni A,Pignatelli M,Ong C,Fumis L,Karamanis N,Carmona M,Faulconbridge A,Hercules A,McAuley E,Miranda A,Peat G,Spitzer M,Barrett J,Hulcoop DG,Papa E,Koscielny G,Dunham I|Nucleic Acids Res|2018
Removed:
'accessPoints' has been modified:
Before:
REST|https://www.targetvalidation.org/api/latest/|The Target Validation Platform API ('Application Programming Interface') allows programmatic retrieval of our data (evidence, asssociation, targets, diseases) via a set of REST services.
After:
REST|https://docs.targetvalidation.org/tutorials/rest-api|Open Targets Platform API
Added:
REST|https://docs.targetvalidation.org/tutorials/rest-api|Open Targets Platform API
Removed:
REST|https://www.targetvalidation.org/api/latest/|The Target Validation Platform API ('Application Programming Interface') allows programmatic retrieval of our data (evidence, asssociation, targets, diseases) via a set of REST services.
'contactORCID' has been modified:
Before: 0000-0002-6315-0263
After:
Edits to 'https://fairsharing.org/FAIRsharing.3f9n4y' by 'The FAIRsharing Team' at 12:40, 14 Dec 2016 (approved):
'shortname' has been modified:
Before: Open Targets
After: Domain list has changed: Previous values: Approved drugs|| Disease Ontology|| Disease model|process| Epigenetics|| Gene annotation relevant to drug discovery|| Gene-disease relationships|| Genetics|process|http://ontology.neuinfo.org/NIF/DigitalEntities/NIF-Scientific-Discipline.owl#nlx_inv_100628 Genomics|| Human disease|x| Literature abstracts|| Molecular Biology|None| Phenotype|information content entity|http://ontology.neuinfo.org/NIF/DigitalEntities/NIF-Investigation.owl#birnlex_2087 Phenotype and disease association|| Rare disease|None| Target Validation Information|| Target therapeutic class|| Text mining|| Transcriptomics|| drug mode of action|None| drug targets|None| human genetics database|None| New values: Approved drugs|| Disease Ontology|| Disease model|process| Epigenetics|| Gene annotation relevant to drug discovery|| Gene-disease relationships|| Genetics|process|http://ontology.neuinfo.org/NIF/DigitalEntities/NIF-Scientific-Discipline.owl#nlx_inv_100628 Genomics|| Human disease|x| Literature abstracts|| Molecular Biology|None| Phenotype|information content entity|http://ontology.neuinfo.org/NIF/DigitalEntities/NIF-Investigation.owl#birnlex_2087 Phenotype and disease association|| Rare disease|None| Target Validation Information|| Target therapeutic class|| Text mining|| Transcriptomics|| drug mode of action|None| drug targets|None| human genetics database|None| Biomedical Science|None| Countries have changed: Previous values: New values: United Kingdom United States of America Publication List has changed: Previous values: New values: Open Targets: a platform for therapeutic target identification and validation.